MSF Field Research > 1 Published Research and Commentary > Laboratory > Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/112714
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
Chaillet P et al RDT HIV 1 and 2 Transactions.pdf416KbAdobe PDF

Title: Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa.
Authors: Chaillet, Pascale
Tayler-Smith, Katie
Zachariah, Rony
Duclos, Nanfack
Moctar, Diallo
Beelaert, Greet
Fransen, Katrien
Affiliation: Médecins sans Frontiérès, Medical Department, Brussels Operational Center, Brussels, Belgium.
Citation: Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa. 2010, 104 (9):571-6 Trans. R. Soc. Trop. Med. Hyg.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Issue Date: Sep-2010
URI: http://hdl.handle.net/10144/112714
DOI: 10.1016/j.trstmh.2010.05.007
PubMed ID: 20708123
Abstract: With both HIV-1 and HV-2 prevalent in Guinea-Conakry, accurate diagnosis and differentiation is crucial for treatment purposes. Thus, four rapid HIV tests were evaluated for their HIV-1 and HIV-2 diagnostic and discriminative capacity for use in Guinea-Conakry. These included SD Bioline HIV 1/2 3.0 (Standard Diagnostics Inc.), Genie II HIV1/HIV2 (Bio-Rad), First Response HIV Card Test 1-2.0 (PMC Medical) and Immunoflow HIV1-HIV2 (Core Diagnostics). Results were compared with gold standard tests (INNO-LIA HIV-I/II Score) and NEW LAV BLOT II (Bio-Rad). Four hundred and forty three sequential stored HIV-positive serum samples, of known HIV-type, were evaluated. Genie II HIV1/HIV2, Immunoflow HIV1-HIV2 and SD Bioline HIV 1/2 3.0 had 100% sensitivity (95% CI, 98.9-100%) while for First Response HIV Card Test 1-2.0 this was 99.5% (95% CI, 98.2%-99.9%). In terms of discriminatory capacity, Genie II HIV1/HIV2 identified 382/ 384(99.5%) HIV-1 samples, 49/ 52(95%) HIV-2 and 7/7(100%) HIV-positive untypable samples. Immunoflow HIV1-HIV2 identified 99% HIV-1, 67% HIV-2 and all HIV-positive untypable samples. First Response HIV Card Test 1-2.0 identified 94% HIV-1, 64% HIV-2 and 57% HIV-positive untypable samples. SD-Bioline HIV 1/2 3.0 was the worst overall performer identifying 65% HIV-1, 69% HIV-2 and all HIV-positive untypable samples. The use of SD Bioline HIV 1/2 3.0 (the current standard in Guinea-Conakry) as a discriminatory HIV test is poor and may be best replaced by Immunoflow HIV1-HIV2.
Language: en
ISSN: 1878-3503
Rights: Published by Elsevier Archived on this site with the kind permission of Elsevier Ltd. (http://www.sciencedirect.com/science/journal/00359203) and the Royal Society of Tropical Medicine and Hygiene (http://www.rstmh.org/transactions.asp)
Appears in topics: Laboratory

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Jul 4, 2015